It's been 16 days since Tony Humby's trial was scheduled to start, and it's still unclear when the first witnesses will be ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...

Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows ...

Silicon Valley-based Operant AI, which claims to be the world’s only runtime AI application defence platform, is now expanding its presence in India to help businesses protect their AI infrastructure.

Patrick Thompson, the licensed firearm holder who is accused of killing two women and injuring three others last month, was ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

AXISCADES Technologies' Mistral Solutions partners with Altera for high-performance computing solutions in aerospace and ...

Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.

The South African National Defence Force (SANDF) has opened its Military Skills Development System (MSDS) applications for 2026, allowing young and deserving South Africans the chance to join the ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Downtown Sudbury, the business improvement association, said it agrees with Lefebvre’s approach to bolster Canadian companies ...

Supplemental New Drug Application (sNDA) submission anticipated in 3Q 2025 ...